Baxter Unveils Next-Gen THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a global leader in medical technology, has launched its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. This innovative system is designed to support daily therapy…
Superior HealthPlan Introduces Assessment Tool to Connect Texans with Community Support
Superior HealthPlan, a prominent managed care organization in Texas and part of Centene Corporation (NYSE: CNC), has launched a new screening tool designed to help Texans access community resources more easily. This assessment focuses on non-medical drivers of health—barriers that…
Centene’s Health Net Awarded California Medicaid Dental Contract for LA and Sacramento
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to enhancing health outcomes, announced that its subsidiary, Health Net Community Solutions, has been chosen by the California Department of Health Care Services to provide managed dental care services to Medi-Cal…
Varian Partners with Ballad Health for 10-Year Oncology Initiative in Rural Areas
Varian, a Siemens Healthineers company, has announced a 10-year agreement with Ballad Health to enhance oncology treatment services for patients in rural communities across the Appalachian Highlands, including Northeast Tennessee, Southwest Virginia, northwestern North Carolina, and southeastern Kentucky. This transformative…
HCA Healthcare Unveils 2024 Awards of Distinction
HCA Healthcare, Inc. (NYSE:HCA), a leading healthcare provider in the nation, presented its annual HCA Healthcare Awards of Distinction during a ceremony in Nashville, Tennessee. These awards, including the Frist Humanitarian Award, the HCA Healthcare Innovators Award, and the HCA…
CVS Health® Prepares to Support Customers and Colleagues as Hurricane Helene Approaches
CVS Health® (NYSE: CVS) is proactively preparing for the impending landfall of Hurricane Helene in Florida. The company prioritizes the health and safety of its customers, members, and employees, aiming to provide communities with essential products and services ahead of…
Estrella Immunopharma’s ARTEMIS® T-Cell Therapy Leads to Complete Remission in First Patient
Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW), a clinical-stage biopharmaceutical company specializing in ARTEMIS® T-cell therapies targeting CD19 and CD22 for cancer and autoimmune disease treatment, has announced that the first patient in the Phase I/II STARLIGHT-1 clinical trial achieved complete…
Iambic Therapeutics Recognized in Endpoints 11 Most Promising Biotech Startups
Iambic Therapeutics, a clinical-stage biotech company harnessing its AI-driven discovery platform, has been named to the 2024 Endpoints News list of “Biotech’s Most Promising Startups.” This annual award highlights innovative life science companies working to develop breakthrough therapies. “By integrating…
Bristol Myers Squibb Unveils Sotyktu Efficacy Data for Scalp Psoriasis in Two Trials
Bristol Myers Squibb (NYSE:BMY) has announced promising results from the Phase 3b/4 PSORIATYK SCALP trial, which assessed the efficacy of Sotyktu (deucravacitinib) in treating patients with moderate-to-severe scalp psoriasis, including those with less extensive psoriasis. The trial met its primary…
Naveris Unveils NavDx® Test Data for HPV-Linked Oropharyngeal Cancer at 2024 AAO-HNS Meeting
Naveris, Inc., a leader in precision oncology diagnostics for viral-induced cancers, announced new data presentation at the 2024 Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), held from September 28 to October 1, 2024, in Miami…
Next Health to Open Proactive Healthcare Centers in Tampa and St. Petersburg
Next Health, a leader in proactive healthcare, is set to open two health optimization and longevity centers in Tampa and St. Petersburg under an area development agreement. This move comes after the brand’s recent expansion in Florida, where it added…
New Data: DecisionDx®-SCC Outperforms BWH Staging for High-Risk Skin Cancer Treatment
Castle Biosciences, Inc. (Nasdaq: CSTL), a company focused on improving health through innovative diagnostic tests, announced new data showing that its DecisionDx-SCC test offers clinically significant risk stratification for high-risk SCC patients, particularly those with suppressed immune systems. This enhanced…